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Abstract
Background: National policy in India recommends HIV testing of all patients with TB. In West Bengal state, only 28% of
patients with TB were tested for HIV between April-June, 2010. We conducted a cross-sectional survey to understand
patient, provider and health system related factors associated with low uptake of HIV testing among patients with TB.
Methods: We reviewed TB and HIV program records to assess the HIV testing status of patients registered for anti-TB
treatment from July-September 2010 in South-24-Parganas district, West Bengal, assessed availability of HIV testing kits and
interviewed a random sample of patients with TB and providers.
Results: Among 1633 patients with TB with unknown HIV status at the time of diagnosis, 435 (26%) were tested for HIV
within the intensive phase of TB treatment. Patients diagnosed with and treated for TB at facilities with co-located HIV
testing services were more likely to get tested for HIV than at facilities without [RR = 1.27, (95% CI 1.20–3.35)]. Among 169
patients interviewed, 67 reported they were referred for HIV testing, among whom 47 were tested. During interviews,
providers attributed the low proportion of patients with TB being referred and tested for HIV to inadequate knowledge
among providers about the national policy, belief that patients will not test for HIV even if they are referred, shortage of HIV
testing kits, and inadequate supervision by both programs.
Discussion: In West Bengal, poor uptake of HIV testing among patients with TB was associated with absence of HIV testing
services at sites providing TB care services and to poor referral practices among providers. Comprehensive strategies to
change providers’ beliefs and practices, decentralization of HIV testing to all TB care centers, and improved HIV test kit
supply chain management may increase the proportion of patients with TB who are tested for HIV.
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Introduction
Early HIV testing for all patients with Tuberculosis (TB)
followed by provision of cotrimoxazole prophylaxis therapy (CPT)
and early initiation of antiretroviral therapy (ART) for those found
to be HIV positive has been shown to reduce mortality among
patients with both TB disease and HIV infection (hereafter
referred to as TB/HIV) [1]. India has the highest absolute number
of TB cases and the second highest number of TB/HIV cases in
the world [2,3]. The initial 2007 national framework for joint
collaboration between the Revised National TB Control Program
(RNTCP) and the National AIDS Control Program (NACP)
promoted selective referral of patients with ‘‘high risk’’ behavior
(e.g. truck drivers or sex-workers who were not responding to anti-
TB treatment) for HIV counseling and testing at the nearest HIV
testing center (Integrated Counseling and Testing Centre, ICTC).
ICTC are managed by the NACP and are either ‘stand-alone’
HIV-testing facilities or located adjacent to clinical care facilities.
The framework was revised in 2008 to recommend provider-
initiated HIV testing and counseling (PITC) for all patients
registered for TB treatment as recommended by WHO and
UNAIDS [4]. The policy of referring all patients diagnosed with
TB to the nearest HIV testing center and getting them tested for
HIV is being scaled-up in a phased manner with a vision of
achieving nationwide coverage by the end of 2012 [5]. HIV testing
is the entry point to the HIV care continuum for people with TB
who have undiagnosed HIV and is provided free of cost by the
NACP [6]. Between April and June 2010, in 16 states of India
implementing PITC, 61% (121,688/199,944) of patients regis-
tered for TB treatment had documented HIV status [3].
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In the eastern Indian state of West Bengal, preparatory activities
for implementation of PITC for patients with TB were completed
by March 2010. These activities included sensitization and
training of TB program managers and all levels of medical and
para-medical staff using standard training modules developed by
both the national TB and HIV programs. However, in the first
quarter of implementation of PITC (April through June, 2010),
only 28% (7,936/28,367) of patients with TB in West Bengal had
documented HIV status, ranging from 0–40% among the 19
districts of the state [3]. We aimed to understand the factors
associated with poor uptake of HIV testing among patients with
TB in order to facilitate necessary corrective actions. The present
study was carried out in South 24 Parganas, one of the largest
districts in West Bengal State, in order to assess patient, provider,
and health system related factors for poor uptake of HIV testing
during the initial intensive phase of patients’ anti-TB treatment.
Methods
Ethics Statement
All records reviewed as part of this study are routinely collected
and documented by RNTCP and NACP in India. Participation in
interviews was entirely voluntary and we obtained written
informed consent from all adult participants or from a parent of
participants aged less than 15 years. Interviewers were blinded to
the HIV testing status of participants. A total of three interview
attempts were made for patients who could not be located initially.
The entire study protocol was reviewed and approved by
Institutional Ethics Committee of National TB Institute, Banga-
lore, India and Ethics Advisory Group of the International Union
against TB and Lung Disease. Approval to conduct the study was
obtained from Central TB Division and the State Health
department.
Study Design
This was a cross sectional study and the study procedures
encompassed a mix of quantitative and qualitative data collection
methods: 1) record review (from both TB and HIV programs) for
all patients registered for TB treatment in South Parganas 24
District, 2) review of records documenting TB/HIV training for
individual health personnel of the district, 3) review of HIV test-kit
stock registers, 4) interview of a subset of patients with TB and 5)
interview and focus group discussion (FGD) with TB care
providers and HIV care providers.
Setting
South 24 Parganas District (population 7.7 million) is primarily
a rural district of West Bengal with a HIV sero-prevalence of more
than 1% among antenatal women [6]. Prevalence of HIV among
people with TB is not known. TB control program services are
available through a decentralized network of 102 general health
care facilities. In addition, patients also frequently utilize health
facilities in the city of Kolkata, located in an adjacent district, and
subsequently complete treatment at one of the health care facility
in South 24 Parganas districts. In accordance with RNTCP
guidelines [7], the 102 South 24 Parganas facilities are grouped
into 15 sub-district level TB program management units (TU) so
each TU has 4 to 12 health care facilities. Patients with TB are
registered within one month of treatment initiation, at one of the
15 TUs and are treated with standardized treatment regimens
administered under direct observation. TB treatment consists of
intensive phase (IP) for 2 to 3 months and continuation phase for 4
to 5 months. Each TU has a TB register maintained by a TB
treatment supervisor to document details of patients started on
anti-TB treatment. Register data also include date and place of
diagnosis, date and place of treatment for TB, HIV status, and
outcome of treatment. Each TB treatment supervisor works under
the supervision and guidance of a Medical Officer of TB Control
(MOTC). Of 102 health institutions that provide TB treatment
services, 14 have a co-located HIV testing center called the
Integrated Counseling and Testing Centre (ICTC). Each of the
remaining 88 health institutions is affiliated with one of these 14
ICTCs in order to provide access to HIV testing services for their
patients. Each ICTC is staffed by a counsellor and a lab-technician
and is monitored by the NACP. HIV testing consists of one rapid
test which if found positive is followed by two confirmatory rapid
tests [8]. Details of each client (name, age, sex and address)
attending the ICTC are documented in an identification register
referred to as the Person Identification Digit (PID) register. The
HIV test results are documented in a separate ICTC register using
the unique PID number for each patient from the PID register.
Study Population and Study Period
1) The study population included all patients with TB registered
for treatment under RNTCP in South 24 Parganas district
from 1st July to 30th September 2010. Patients with ‘‘known
HIV status’’ (defined as any prior positive test result or as a
negative result for a test performed within six months prior to
diagnosis of TB) were excluded from the study.
2) All health care providers from TB and HIV services in the
district formed the sampling frame for provider interviews.
The study was conducted during the period July 2010– March
2011.
Data Source, Sample Size, Sampling Method and
Variables
The primary outcome variable was failure to be tested for HIV by
the end of IP of anti-TB treatment. National guidelines
recommend referral for HIV testing as soon as possible after
diagnosis of TB; hence, in the present study, the time limit for
defining the outcome variables was the end of the IP of treatment
(i.e. 2 months for new cases and 3 months for retreatment cases).
Multiple methods of data collection were used including the
following quantitative and qualitative components:
Record review- quantitative component. We reviewed
both TB and HIV program records. We used structured data
collection sheets to abstract data for all patients registered at the
South 24 Parganas TUs. We documented the following variables
from the TB register: age, sex, history of previous TB treatment,
classification of TB and health facility where TB was diagnosed
and got treatment respectively. We reviewed PID and ICTC
registers at the ICTCs linked to the health facilities where patients
with TB were diagnosed and where patients received treatment, if
diagnosis and treatment occurred at different facilities linked to
different ICTC. For patients with TB treatment records that
indicated they were diagnosed with TB at a facility outside of
South 24 Parganas (e.g., in Kolkata) we also reviewed the PID and
ICTC registers at the ICTC linked to the facility where the patient
was diagnosed. We linked TB treatment register and PID register
data using patient name, age and address to determine whether a
patient with TB attended the ICTC linked to either the site of TB
diagnosis or treatment. If the name was found in the PID register,
the ICTC register was searched to determine whether the patient
was tested for HIV. A patient with TB was considered to have
been tested for HIV if his or her name and test results could be
located in PID and ICTC registers. We noted the date of testing
Barriers to HIV Testing in Patients with TB, India
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for HIV in our structured data collection sheet. If a matching
patient record was not found in the ICTC register for dates
corresponding to the intensive phase of TB treatment, we searched
for matching records from the 6 months prior to treatment
initiation. If we found a matching ICTC record for a date within
six months before the date of TB diagnosis, the patient was
considered to have known HIV status. Although HIV status with
date of testing was sometimes documented in the TB registers, we
did not use the TB registers as a source of HIV status data because
they were found to be incomplete at 10 of 15 TUs. We derived the
following variables from the extracted data: colocation (meaning
TB and HIV services available at the same facility) of either the
facility at which the patient was diagnosed with or treated for TB,
residence type (urban or rural), approximate distance (to the
nearest kilometer) between patients’ home and the ICTC linked to
the health facility providing TB treatment services, type of health
facility (medical college hospital or sub-division hospital or
Primary Health Center) where each patient received TB diagnosis
and time gap between TB diagnosis and HIV testing (for those
who got tested for HIV). The approximate distance between
patient’s home and the ICTC was ascertained by the field health
care workers of the general health system. If a patient utilized
different facilities for diagnosis and treatment, distance between
the patient’s home and the ICTC linked to the treatment facility
was calculated because in all cases the treatment facility closer to
the patient’s home.
We reviewed South 24 Parganas District training log registers
and noted whether providers of TB services and of HIV services
had participated in the training on TB/HIV integration. We
reviewed the minutes of district level monthly meetings to
determine what information hospital healthcare workers had been
exposed to regarding TB/HIV collaborative activities. At each
ICTC within South 24 Parganas, the number of HIV testing kits
supplied and consumed per month was extracted from stock
registers. We reviewed ICTC registers to determine the total
number of patients tested for HIV each month, by patient group
(e.g., referred from antenatal clinic, referred because of diagnosis
of TB, referred from outpatient or in-patient wards, walk-in).
Patient interview- quantitative component. We selected a subset
of patients enrolled for anti-TB treatment by simple random
sampling. The sample size needed was calculated to detect an odds
ratio of 1.5 (between failure to test for HIV and tested for HIV)
with 80% power and 95% confidence for the variable ‘‘distance
between home and ICTC more than 10 kms’’. The estimated
sample size of 168 was increased to 204 anticipating that 20% of
patients selected would not complete the interviews either due to
absence, hospitalization or refusal. We used a pre-tested semi-
structured interview schedule (SSIS) and conducted interviews
within a week after completion of the IP of treatment. The
variables assessed were marital status, income group, literacy,
occupation, referred for HIV test or not, counseled or not,
category of provider who referred for HIV testing, and timing of
referral.
Questionnaires for patients were translated and back-translated
to the local language (Bengali) and pre-tested before use. Patient
interviews were conducted by five trained interviewers in Bengali.
Two supervisors cross checked the interviews for completeness and
accuracy.
Provider interviews and Focus Group Discussions (FGD)-
qualitative component. We held provider interviews and FGDs
after we had analyzed the quantitative data available from records
and patient interviews. We selected a convenience sample of
Medical Officers (MO) and health workers who provided directly
observed therapy to patients with TB (DOT providers) for
interviews from the existing 102 health care facilities in the study
district, based on 1) magnitude of referral for HIV testing and 2)
presence or absence of ICTC in the health facility. At least one
provider (MO or DOT provider) was chosen from each of the 15
TB units. We conducted two FGDs, one with all of the TB
treatment supervisors from 15 TB units and one with all of the
counselors from 14 ICTCs. Using an open ended questionnaire we
asked providers about their awareness of national policy on TB/
HIV program collaboration and whether they had been trained in
TB/HIV program collaboration. We asked questions to assess
their perceptions about the policy of routine referral of patients
with TB for HIV testing and reasons for not referring patients with
TB for HIV counseling and testing. We ascertained provider
knowledge of recording and reporting procedures of PITC using a
set of open ended questions during FGDs. The Principal
Investigator (PI) conducted and recorded interviews with providers
in English and conducted and recorded results of FGDs in Bengali.
All Bengali transcripts of FGDs were translated to English before
analysis.
Data Handling and Analysis
Quantitative data from the data collection sheet and patient
interviews were double-entered into Epi-Info software version
3.5.3 (Center of Disease Control and Prevention, Atlanta, USA),
by independent data entry operators. Databases were compared
and inconsistencies resolved through referral to the original data
collection sheet. Statistical analysis was performed using SPSS
software version 13.0. Relative risks with 95% confidence intervals
(CI) were calculated for association between each exposure
variable and the outcome of interest (failure to be tested for
HIV within IP). Chi square (x2) tests were used for comparing
proportions and p values ,0.05 were considered statistically
significant.
We used inductive analysis for qualitative data obtained from
provider responses and FGDs (i.e., categories of analysis were not
imposed a priori on the data but were identified through the
analysis process) [9]. Provider perceptions about why patients with
TB were not being tested for HIV during the IP were noted on
spreadsheets. Similar answers were coded manually by the




Of 1,651 patients registered for TB treatment, 18 (1%) had
documentation of HIV test performed within six months prior to
the time of TB diagnosis (i.e. had known HIV status) and were
excluded from the study. Of 1,633 patients with TB included in
the study, 1,555 (96%) were adults ($15 years), 1167 (72%) were
males, 1,375 (84%) lived in rural areas, and 1,356 (82%) did not
have history of previous anti-TB treatment. A total of 1195 (73%)
patients were diagnosed with TB in primary health centers, 325
(20%) in sub-divisional hospitals and 113 (7%) in medical college
hospitals (Table 1). In addition to the health facilities in South 24
Parganas District, patients were also diagnosed with TB at twenty
five other health facilities in the neighboring districts. Of 1,633
patients with unknown HIV status at the time of TB diagnosis, 425
(26%) were tested for HIV by the end of IP. Of these, 362/425
(85%) were tested within the first 15 days of initiation of treatment.
Of all patients tested for HIV, 8 (2%) had a positive result.
Relative to patients diagnosed with or treated for TB at a facility
with collocated ICTC, risk of failure to be tested for HIV were
higher for patients diagnosed with or treated for TB in facilities
Barriers to HIV Testing in Patients with TB, India
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without a co-located ICTC (RR 1.27, 95% CI 1.20–1.35). Age,
sex, positive sputum test result and history of prior TB treatment
were not associated with failure to receive testing for HIV
(Table 2).
Review of Training Register and HIV Testing Kit Stock
Registers
The RNTCP district program manager, NACP district
program manager, all MOTCs, all TB supervisors at the 15
TUs, and all counselors of 14 ICTCs were found to have been
formally trained using the standard TB/HIV training modules.
Other medical officers and healthcare workers were not trained
formally but were informed of the national policy of ‘routine offer
of HIV testing for all patients with TB’ in their regular monthly
meetings. From July through September 2010, there were no test
kits available at 6 of 14 ICTCs for periods ranging from 10 to 20
days. However, at the district level, there were more test kits
distributed to ICTCs than were used.
Patient Interviews
Of the 204 patients randomly selected, 169 (83%) were
interviewed, 25 were unavailable even after three attempts, and
10 died before they could be interviewed. Of 169 patients
interviewed, six were children under 15 years so we interviewed
the parent who accompanied the children during the TB diagnosis
process. There was no statistically significant difference between
patients who were interviewed compared to all patients enrolled by
age group, sex, completion of HIV testing during IP, residence
type or history of previous treatment (data not shown). Of 169
patients interviewed, only 67 (40%) reported that they were
referred for HIV testing and of these, 53 (79%) went to an ICTC.
Of the 53 patients who went to an ICTC, 47 (89%) were tested for
HIV and 6 (11%) were not. Of the 47 patients tested for HIV, 25
(47%) reported that they were counseled prior to being tested. Of
67 patients who reported that they were referred for HIV testing,
41 (61%) reported they were not informed of the purpose of the
test by the TB care provider.
Of the six patients who reported that they went to ICTC after
being referred for testing but did not get tested, two (33%)
reported that they did not get tested because the ICTC was closed
Table 1. Demographic and clinical characteristics of patients with TB (n = 1,633) registered for treatment from July – September,
2010 in South 24 Parganas District, West Bengal State, India.
Category Subcategory Number %
Sex Male 1167 71.5
Female 466 28.5







Distance of nearest ICTC* from house (km) ,10 kms 403 24.7
10–39 kms 1100 67.4
.40 kms 130 8
Residence location Rural 1375 84.2
Urban 258 15.8
History of treatment New 1356 83.0
Previously treated 277 17.0
Type of TB Smear Positive Pulmonary TB 1009 61.8
Smear Negative Pulmonary TB 353 21.6
Extra Pulmonary TB 271 16.6
Location of TB diagnosis Primary Health Centers 785 48.1
Primary Health Centers having a Tuberculosis Unit Headquarter 410 25.0
District/Sub Divisional Hospital 59 3.7
District/Sub Divisional Hospital with Tuberculosis Unit Headquarter 266 16.2
Medical College Hospital 113 6.9
HIV testing status Not tested during Intensive Phase (IP) 1208 74.0
Tested during Intensive Phase 425 26.0
Timing of HIV testing (n = 425**) #15 days of TB treatment initiation 362 85.2
.15 days but within IP of TB treatment 63 14.8
ICTC = Integrated Counseling and Testing Centre (HIV testing centers),
**only for those who got HIV tested during the intensive phase.
doi:10.1371/journal.pone.0055229.t001
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and four (66%) reported that there were no counselors to conduct
HIV counseling or testing. Of the 14 persons who were referred
but did not go to ICTC, eight (57%) reported they thought that
the test was not necessary, four (29%) reported that the ICTC was
too far and two (14%) reported that they were told by the TB
program staff to go for HIV testing at another time because testing
kits were not available but did not go for testing at a later date. Of
these 14 persons referred to ICTC but who did not go, 3 were
referred from a facility that was co-located with an ICTC. In total,
122/167 (72%) of interviewed patients were not tested for HIV
during the IP of anti-TB treatment (Table 3).
Among patients who reported that they were referred for HIV
testing, patients who reported being referred by a DOT worker
had higher risk of not undergoing HIV testing relative to patients
who reported being referred by a Medical Officer (RR 3.53, 95%
CI 1.62–9.57). We found that among patients referred by DOT
workers 12/29 (41%) were exposed to co-located facilities
compared to 22/38 (58%) of patients referred by Medical.
Patients referred for HIV testing during anti-TB treatment were
less likely to get tested relative to patients referred at the time of
diagnosis (RR 2.91, 95% CI 1.19–7.10), (Table 4). Patients’
marital status, literacy, occupation and income were not signifi-
cantly associated with failure to get HIV tested. Among patients
diagnosed with TB, 43% (34/79) of patients diagnosed in a facility
with a co-located ICTC were referred for HIV testing compared
to 36% (33/90) of patients diagnosed at a facility without a co-
located ICTC.
Provider Interviews and Focus Group Discussions (FGD)
Key informant interviews were conducted with 16 MOs and
four DOT providers. More than half (13/20) of providers reported
awareness of the policy to refer all patients with TB for HIV
testing and 35% (7/20) reported that program managers of both
the national TB control and AIDS control programs provided
minimal supervisory support. Almost all providers (17/20) believed
that patients would not undergo HIV testing even when
recommended by a provider. Most providers (15/20) reported
that they had not been formally trained using standard-HIV
training modules, and that they do not regularly refer all patients
with TB for HIV testing. We learned that providers do not refer
for HIV testing because they believe that ICTCs are not co-
located with TB facilities, that they are too far for patients to travel
especially in view of poor public transport facilities, and that
ICTCs provided irregular service and frequently suffered from
HIV testing kit shortages (Table 5). Providers felt that very few
patients were likely to be HIV positive and therefore questioned
the rationale for referring patients for testing.
In FGD, TB treatment supervisors indicated that they had
received training on TB/HIV guidelines but were not yet
conversant with correct reporting procedures. They also shared
concerns about the shortage of HIV testing kits and felt that
physicians were apathetic towards referral of HIV testing for
patients with TB. ICTC counselors indicated that they receive few
referrals for HIV testing from TB treatment providers, minimal
Table 2. Factors associated with failure to test for HIV among patients with TB in South 24 Parganas District, West Bengal State,
India, July-September 2010.
Category
Failed to test for HIV
during IP*
(n = 1208)
Tested for HIV in IP*
(n = 425) Relative Risk
95% Confidence
Interval P Value
n (%) n (%)
Age in years
0–14 55 (69.6) 24 (30.4) 0.90 0.76–1.06 0.19
15–24 292 (71.4) 117 (28.6) 0.92 0.83–1.02 0.14
25–34 222 (71.2) 90 (28.8) 0.92 0.82–1.02 0.14
35–44 212 (77.1) 63 (22.9) 0.99 0.90–1.11 0.92
45–54 181 (78.4) 50 (21.6) 1.01 0.91–1.13 0.84
55–64 122 (73.1) 45 (26.9) 0.94 0.83–1.07 0.35
Above 65 124 (77.5) 36 (22.5) REF
Sex
Male 872 (74.7) 295 (25.3) 1.04 0.97–1.11 0.27
Female 336 (72.1) 130 (27.9) REF
Co-location of TB and HIV testing services
Not Co-located 672 (83.0) 138 (17.0) 1.27 1.20–1.35 ,0.01
Co-located 536 (65.1) 287 (34.9) REF
Type of TB
Smear Positive Pulmonary TB 736 (72.9) 273 (27.1) 0.94 0.87–1.01 0.13
Smear Negative Pulmonary TB 262 (74.2) 91 (25.8) 0.96 0.88–1.05 0.34
Extra Pulmonary TB 210 (77.6) 61 (22.4) REF
History of previous treatment
New 1002 (73.9) 354 (26.1) 0.99 0.92–1.07 0.88
Previously treated 206 (74.4) 71 (25.6) REF
*IP = Intensive phase of TB treatment.
doi:10.1371/journal.pone.0055229.t002
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supportive supervision from both TB and HIV programs, and
intermittent stock outs of kits.
Discussion
Nearly three-fourths of patients with TB in South 24-Parganas
district, West Bengal, were not tested for HIV during the intensive
phase of TB treatment. Based on our data we believe that a key
reason that patients were not tested for HIV was that they were
not routinely referred for testing by TB treatment providers. We
found that testing for HIV was strongly associated with receiving
TB treatment or diagnostic services at a facility that had on-site
HIV testing services; however at South 24-Parganas facilities both
with and without on-site HIV testing services patients reported low
rates of referral for HIV testing. Providers indicated that they often
do not refer patients for HIV testing because they believe that
patients will not present for HIV testing because ICTCs are
located too far away, or because HIV testing kits are not
consistently available at ICTCs. We also found that health system
factors rather than patient factors are responsible for low levels of
testing. Several HIV testing centers had intermittent stock-outs of
test kits during the study period, though the total number of HIV
test kits at district level was adequate compared to the number
used at ICTC, suggesting that supply chain management was sub-
optimal. Though national policy is to provide training on TB/
HIV to all health care providers, formal training was provided
only to a few key staff of RNTCP and NACP. In contrast to
studies in South India [11], East Asia [12–14] and African
countries [15–18], our study in an Eastern India district showed
that failure to test was not associated with any demographic or
clinical characteristics of patients.
Our findings support the importance of co-location of HIV
testing and TB care services as demonstrated in some Asian [12–
14] and African [19,20] countries. Through our study we were
also able to demonstrate the importance of HIV test kit supply
chain management. Most importantly, our study highlights
provider knowledge, beliefs, and practices that may be a barrier
to HIV testing for patients with TB. Similar provider beliefs have
been reported in Uganda [15], Tanzania [21] and Ukraine [22].
In Karnataka, a state in South India, the uptake of HIV testing
was 84% in the same period as this study [3]. However, Karnataka
is a state with high HIV prevalence and with decentralized and
widely available HIV testing services. In contrast, West Bengal has
much lower HIV prevalence and fewer HIV testing services. HIV
Table 3. Patient characteristics and HIV test referral
outcomes as reported in interviews with patients with TB
(n = 169) registered for treatment between July to September
2010, South 24 Parganas District, West Bengal State, India.













Referral for HIV testing
Not referred 102 60
Referred 67 40
Reaching HIV testing centre (N = 67#)
Did not go to ICTC** after referral 14 21
Went to ICTC after referral 53 79
HIV testing (N = 53##)
Not tested 6 11
Tested 47 89
*100 INR (Indian rupees) = 2.2 USD (US Dollars) as on 1st September 2011,
**ICTC = Integrated Counseling and Testing Centre (HIV testing centers);
#only among those who were referred;
##only among those who reached ICTC.
doi:10.1371/journal.pone.0055229.t003
Table 4. Factors associated with failure to be tested for HIV among patients with TB who reported being referred for HIV testing
after TB diagnosis was made in South 24 Parganas District, West Bengal State, India – July–September, 2010.
Category
Failed to be tested
for HIV in IP
n = 20
Tested for HIV during
IP*




n (%) n (%) – – –
Referring Person
Referral by DOT workers 15 (52) 14 (48) 3.53 1.62–9.57 ,0.01
Referral by Medical Officers 5 (13) 33 (87) REF
Time of Referral
During TB treatment 15 (44) 19 (56) 2.91 1.19–7.10 ,0.01
At TB diagnosis 5 (15) 28 (85) REF
Method of Referral
Referral form not used 15 (36) 27 (64) 1.79 0.74–4.32 0.17
Referral form used 5 (20) 20 (80) REF
*IP = Intensive phase of TB treatment.
doi:10.1371/journal.pone.0055229.t004
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awareness among the community in West Bengal remains lower
than reported in states of India that have higher HIV prevalence
[23]. Our findings that at least half of patients with TB were not
referred for HIV testing, were not informed what the test was for,
and were not counseled prior to HIV testing indicates there are
gaps between national policy and local implementation. One
explanation for the observed low levels of provider knowledge and
poor referral practices is that West Bengal has a relatively low HIV
prevalence so providers there may have less experience in caring
for patients with HIV infection just as in other low prevalence
settings [24,25].
Increasing ease of access to HIV testing can increase uptake of
PITC. Examples of strategies to increase HIV testing among
patients with TB that have been successfully implemented in other
settings include provision of both TB and HIV services by a single
health provider as in Kwazulu-Natal and co-locating TB
treatment and HIV testing services as in Khayelistha, South
Africa [26]. Robust logistic supply-utilization management may be
used to prevent even brief shortages of HIV testing kits as
demonstrated in Uganda [15]. Increasing community awareness of
the link between TB and HIV may also increase testing for HIV.
In Kenya, an increase in HIV testing from 32% to 59% was
observed when patients with TB were provided health education
before the national scale-up of routine HIV testing. Based on our
data and other research, we believe that TB/HIV training for all
appropriate staff, supportive supervision, and effective supply
management of HIV test kits can improve HIV testing among
people with TB [27].
Our study had several limitations. Information on referral of
patients for HIV testing by TB care providers was based on
patients’ self-report. Although we cannot exclude possible recall or
reporting bias, particularly according to whether or not a patient
was referred for testing, our finding of low rates of referral for HIV
testing is consistent with information from our provider interviews
and FGDs. Although facility meeting minutes provided evidence
of sensitization of providers to HIV testing of patients with TB,
were not able to assess the proportion of providers sensitized. We
also could not verify all subjective claims made by providers, for
example that ICTCs have staff shortages and irregular hours of
operation. Addressing this limitation in future studies would
provide an evidence base to recommend mitigation of some of
these issues ascertained. Though the present study was conducted
in one district, challenges identified in this study are likely to be
common to other districts of West Bengal state, which are also in
the initial phase of implementing HIV testing among patients with
TB. Thus these study findings will help in formulating and
prioritizing operational procedures to strengthen existing TB/HIV
collaborative activities in the state. Because TB/HIV collaborative
activities are being implemented in a phased manner in India,
results from this study may inform activities as they are
implemented and scaled up in other parts of India.
Universal HIV testing in persons with TB has not yet been
achieved in West Bengal. This represents a missed opportunity for
HIV testing, counseling and ART services which in turn prevent
excess morbidity and mortality associated with HIV infection in
patients with TB [28–30]. Comprehensive strategies to change
providers’ beliefs regarding referral for HIV testing of all people
with TB, formal training of all providers in TB/HIV collaborative
activities, decentralization of HIV testing to all TB care centers or
direct provision of HIV testing by TB clinic staff, and improved
HIV test kit supply chain management may increase uptake of
HIV testing among patients with TB.
Table 5. Perception of Providers on barriers to HIV testing for people with TB in South 24 Parganas District, West Bengal, India.
Barriers Providers Citations Type of Respondent
Lack of knowledge on TB-HIV
guidelines
‘‘Those TB patients who have high risk behavior need to be tested for HIV’’ (Medical Officer of a sub-divisional Hospital with
ICTC*)
‘‘Those who are not responding to TB treatment need to be tested for HIV’’ (Medical Officer of a Health centre without ICTC)
‘‘Is there any Government order to send TB patients for HIV testing?’’ (Medical Officer of a Health centre without ICTC)
Perception that ICTC is too far for
patients to go
‘‘Patients do not want to go to ICTC leaving their work’’ (Medical Officer of a Health centre with ICTC)
‘‘ICTC is very far from here. This is a river delta island’’ (Medical Officer of a Health centre with ICTC)
Perception that ICTC is not
providing patient friendly services
‘‘Patients are made to wait a long time. Sometimes they complain of rude
behavior. They are made to come again and again’’
(DOT Provider of a sub-divisional Hospital with
ICTC)
‘‘ICTC is not open regularly. They are monitored from higher level and
we do not know much about their functioning’’
(Medical Officer of a sub-divisional Hospital with
ICTC)
‘‘ICTC is too crowded as ante natal mothers are also tested here.
Patients get their results after a week’’
(TB treatment supervisor of one TB Unit)
‘‘No one knows what the ICTCs do. No one monitors their work and
they do not listen to anyone’’
(Medical Officer of a sub-divisional Hospital with
ICTC)
Perception that there is shortage
of testing kits
‘‘Kits are short supply I heard, we are told not to refer too many patients’’ (Medical Officer of a Health centre with ICTC)
Perception that patients will not
undergo testing if informed the
test is for HIV
‘‘Patients do not understand what is HIV’’ (Medical Officer of a Health centre with ICTC)
‘‘I don’t think they will go for the testing if they know it is for HIV’’ (Medical Officer of a Health centre with ICTC)
‘‘They may not get the test done once they know they have already
been diagnosed of TB’’
(Medical Officer of a Health centre with ICTC)
*ICTC = Integrated Counseling and Testing Centre (HIV testing centers).
doi:10.1371/journal.pone.0055229.t005
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